Evidence map›Paper›PMID 39671024›Full record

Trial reportEuropean journal of applied physiology2025

Acute effects of intra-training carbohydrate ingestion in CrossFit® trained adults: a randomized, triple-blind, placebo-controlled crossover trial.

Alejandro R Triviño, Carlos Díaz-Romero, Juan J Martin-Olmedo, Pablo Jiménez-Martínez, Carlos Alix-Fages, Magdalena Cwiklinska, Daniela Pérez, Lucas Jurado-Fasoli

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European journal of applied physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06440343 (Effects of Acute Carbohydrate Intake Intra-training in Crosstraining Athletes), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06440343 nacompletednot on this map

Effects of Acute Carbohydrate Intake Intra-training in Crosstraining Athletes: a Randomized, Placebo-controlled Crossover Study

TypeinterventionalSponsorUniversidad de GranadaRan2024 to 2024Enrolled25ConditionsRecoveryArmsCarbohydrates, Placebo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alejandro R TriviñoDepartment of Chemical and Pharmaceutical Technology Engineering, University of La Laguna, Santa Cruz de Tenerife, Spain. alu0101614137@ull.edu.es.ORCID http://orcid.org/0009-0001-4363-6557
Carlos Díaz-RomeroDepartment of Chemical and Pharmaceutical Technology Engineering, University of La Laguna, Santa Cruz de Tenerife, Spain.
Juan J Martin-OlmedoDepartment of Physiology, Faculty of Medicine, University of Granada, Granada, Spain.
Pablo Jiménez-MartínezResearch Group in Prevention and Health in Exercise and Sport (PHES), University of Valencia, Valencia, Spain.
Carlos Alix-FagesResearch Group in Prevention and Health in Exercise and Sport (PHES), University of Valencia, Valencia, Spain.
Magdalena CwiklinskaICEN Institute, Madrid, Spain.
Daniela PérezNeonatology and UMIP Service, University Hospital Nuestra Señora de La Candelaria, Santa Cruz de Tenerife, Spain.
Lucas Jurado-FasoliDepartment of Physiology, Faculty of Medicine, University of Granada, Granada, Spain. juradofasoli@ugr.es.ORCID http://orcid.org/0000-0002-5254-1816

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carbohydrate (CHO) intake during exercise could decrease the subjective perceived exertion and promote recovery; however, the effects of intra-training CHO ingestion remain uncertain in CrossFit® (CF) sessions. Therefore, the aim of this randomized, triple-blind, placebo-controlled crossover trial was to investigate the effect of acute CHO intake during a CF session on the delayed onset muscle soreness (DOMS), the perceived exertion (RPE), performance, recovery, and metabolic markers (capillary lactate and glucose) in CF athletes. Twenty-three male athletes trained in CF ingested CHO (60 g of maltodextrin + fructose) or a placebo (PLA) during a CF session. DOMS was assessed 24 and 48 h after the CF session. The Counter Movement Jump (CMJ) test and the Deep Squat test at 70% of the athlete's body weight (AST70) were performed before, immediately after, and 24 h after the session. Perceived exertion, Feeling Scale (FS), Gastrointestinal Distress Score (GDS), heart rate, capillary lactate, and glucose were assessed across the session. CHO supplementation did not improve DOMS (all P ≥ 0.127), CMJ, or AST70 parameters (all P ≥ 0.053) compared to PLA. There were no differences between CHO and PLA in RPE, FS, GDS, heart rate (all P ≥ 0.088), performance (e.g., nº of repetitions; all P ≥ 0.556), or lactate levels (P = 0.810). However, glucose levels increased from the back squat to the WOD and remained stable after the AMRAP (P < 0.001). In conclusion, acute CHO intake during a CF session did not improve DOMS, perceived exertion, performance, recovery, or metabolic markers in CF athletes. TRN: NCT06440343. Date: 2024-05-10.

Indexed as

Dietary CarbohydratesExercisePhysical Conditioning, HumanAdultAthletic PerformanceCross-Over StudiesHumansMaleMyalgiaPhysical ExertionPolysaccharidesYoung AdultDietary CarbohydratesmaltodextrinPolysaccharidesCrossFitNutritionPerformanceRecoverySports drink

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.